About Sonata System

About the SONATA SYSTEM

Sonata-System-logo-RGB

Transcervical Fibroid Ablation for Treatment of Symptomatic Uterine Fibroids

A New Point of View

The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure to treat symptomatic uterine fibroids.

  • Delivers a breakthrough alternative to hysterectomy and myomectomy
  • Transcervical delivery avoids the peritoneal cavity and does not require general anaesthetic
  • Treats most fibroid types including submucous, intramural, transmural and subserous

SONATA Pivotal IDE Trial Results Through 3 Years1,2

50% of patients returned to normal activity the next day with an average of 2.2 days
Sonata-InfographicBrochure-RND15-95
Sonata-InfographicBrochure-HMB-92
Sonata-InfographicBrochure-Treatsatisfaction94-OL

1. Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstet Gynecol. 2019; 133:13-22.

2. Lukes A, Green MA. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata. J Gynecol Surg. 2020;36:5, 228-233.

Frequently Asked Questions

Find answers to a few of the questions most frequently asked by healthcare professionals.

Medical and Scientific Information Request

Requests for additional medical and scientific information can be submitted to our Medical Director through the following form.

Instructions for Use

Electronic versions of Sonata System instructions for use (IFU) are available on our company site.

Indication and Safety Information

The Sonata System is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.

Safety Information | Privacy Policy | Terms of Use | Contact Us

Gynesonics, Inc. | 600 Chesapeake Drive | Redwood City, CA 94063 | (650) 216-3860

Copyright 2022  Gynesonics | WS 05195-002UK Rev A